'Preconditioning' with low dose lipopolysaccharide aggravates the organ injury/dysfunction caused by hemorrhagic shock in rats

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Sordi, Regina ^a,b   Chiazza, Fausto ^c   Patel, Nimesh S A ^a   Doyle, Rachel A ^a   Collino, Massimo ^c   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b MINISTRY OF EDUCATION OF BRAZIL   (Brazil)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATININE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHOSPHATE BUFFERED SALINE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; NOS2 PROTEIN, RAT;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; HEMORRHAGIC SHOCK; ISCHEMIA; KIDNEY DYSFUNCTION; KIDNEY LEVEL; LIVER INJURY; LIVER LEVEL; MALE; MEAN ARTERIAL PRESSURE; MUSCLE INJURY; NITRATE METABOLISM; NONHUMAN; ORGAN INJURY; PREMEDICATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; RESUSCITATION; TISSUE LEVEL; ANIMAL; BLOOD; IMMUNOLOGY; KIDNEY; LIVER; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; CYTOKINES; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RATS, WISTAR; SHOCK, HEMORRHAGIC;

EID: 84926636361     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122096     Document Type: Article

References (37)

1. Minei JP, Cuschieri J, Sperry J, Moore EE, West MA, Harbrecht BG, et al. The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. CritCare Med. 2012;40(4):1129-35. doi: 10.1097/CCM.0b013e3182376e9f PMID: 22020243
2. Bond RF, Johnson G 3rd. Vascular adrenergic interactions during hemorrhagic shock. Fed Proc. 1985;44(2):281-9. PMID: 3967773
3. Jiang H, Huang Y, Xu H, Hu R, Li QF. Inhibition of hypoxia inducible factor-1 a ameliorates lung injury induced by trauma and hemorrhagic shock in rats. Acta Pharmacol Sin. 2012;33(5):635-43. doi: 10. 1038/aps.2012.5 PMID: 22465950
4. Thiemermann C, Szabó C, Mitchell JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U SA. 1993;90(1):267-71. PMID: 7678341
5. Cabrales P, Tsai AG, Intaglietta M. Exogenous nitric oxide induces protection during hemorrhagic shock. Resuscitation. 2009;80(6):707-12. doi: 10.1016/j.resuscitation. 2009.03.001 PMID: 19362408
6. Beeson PB. Development of tolerance to typhoid bacterial pyrogen and its abolition by reticulo-endothelial blockade. ProcSoc Exp Biol Med. 1946;61:248-50. PMID: 21024160
7. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care. 2006;10(5):233. PMID: 17044947
8. Karikó K, Weissman D, Welsh FA. Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood FlowMetab. 2004;24(11):1288-304. PMID: 15545925
9. Sivarajah A, McDonald MC, Thiemermann C. The cardioprotective effects of preconditioning with endotoxin, but not ischemia, are abolished by a peroxisome proliferator-activated receptor-gamma antagonist. J Pharmacol ExpTher. 2005;313(2):896-901. PMID: 15734901
10. Gong G, Bai S, Wu W, Hu L, Liu Y, Niu J, et al. Lrg participates in lipopolysaccharide preconditioning-induced brain ischemia injury via TLR4 signaling pathway. J Mol Neurosci. 2014;54(1):20-6. doi: 10. 1007/s12031-014-0240-8 PMID: 24526448
11. Collino M, Patel NS, Lawrence KM, Collin M, Latchman DS, Yaqoob MM, et al. The selective PPAR-gamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. Kidney Int. 2005;68(2):529-36. PMID: 16014029
12. He K, Chen X, Han C, Xu L, Zhang J, Zhang M, et al. Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2oregulated nitric oxide production. Kidney Int. 2014;85(2):276-88. doi: 10.1038/ki.2013.342 PMID: 24025643
13. Merry HE, Wolf PS, Fitzsullivan E, Keech JC, Mulligan MS. Lipopolysaccharide pre-conditioning is protective in lung ischemia-reperfusion injury. J Heart Lung Transplant. 2010;29(4):471-8. doi: 10.1016/j. healun. 2009.11.005 PMID: 20044277
14. Rao J, Qin J, Qian X, Lu L, Wang P, Wu Z, et al. Lipopolysaccharide preconditioning protects hepatocytesfrom ischemia/reperfusion injury (IRI) through inhibiting ATF4-CHOP pathway in mice. PLoS One. 2013;8(6):e65568. doi: 10.1371/journal.pone.0065568 PMID: 23750267
15. Zacharowski K, Otto M, Hafner G, Chatterjee PK, Thiemermann C. Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology. ArteriosclerThromb Vasc Biol. 1999;19(9):2276-80. PMID: 10479673
16. Kumral A, Tuzun F, Ozbal S, Ugur Ergur B, Yilmaz O, Duman N, et al. Lipopolysaccharide-preconditioning protects against endotoxin-induced white matter injury in the neonatal rat brain. Brain Res. 2012;1489:81-9. doi: 10.1016/j.brainres.2012.10.015 PMID: 23063716
17. Millar CG, Thiemermann C. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Br J Pharmacol. 1997;121(8):1824-30. PMID: 9283724
18. Pieber D, Horina G, Sandner-Kiesling A, Pieber TR, Heinemann A. Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats. Cardiovasc Res. 1999;44(1):166-75. PMID: 10615400
19. Rojas A, Padrón J, Caveda L, Palacios M, Moncada S. Role of nitric oxide pathway in the protection against lethal endotoxemia afforded by low doses of lipopolysaccharide. Biochem Biophys Res Commun. 1993;191(2):441-6. PMID: 8461002
20. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298(5600):1911-2. PMID: 12471242
21. Park JH, Jeong YJ, Won HK, Choi SY, Park JH, Oh SM. Activation of TOPK by lipopolysaccharide promotes induction of inducible nitric oxide synthase through NF-kB activity in leukemia cells. Cell Signal. 2014;26(5):849-56. doi: 10.1016/j.cellsig.2014.01.004 PMID: 24440499
22. Kawano T, Kunz A, Abe T, Girouard H, Anrather J, Zhou P, et al. iNOS-derived NOandnox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite. J Cereb Blood FlowMetab. 2007;27(8):1453-62. PMID: 17293848
23. Zager RA, Johnson AC, Lund S. 'Endotoxin tolerance': TNF-alpha hyper-reactivity and tubular cytoresistance in a renal cholesterol loading state. Kidney Int. 2007;71(6):496-503. PMID: 17228359
24. Matulova M, Stepanova H, Sisak F, Havlickova H, Faldynova M, Kyrova K, et al. Cytokine signaling in splenic leukocytes from vaccinated and non-vaccinated chickens after intravenous infection with Salmonella enteritidis. PLoS One. 2012;7(2):e32346. doi: 10.1371/journal.pone.0032346 PMID: 22384225
25. Md S, Moochhala SM, Siew-Yang KL. The role of inducible nitric oxide synthase inhibitor on the arteriolar hyporesponsiveness in hemorrhagic-shocked rats. LifeSci. 2003;73(14):1825-34. PMID: 12888121
26. Wang YP, Sato C, Mizoguchi K, Yamashita Y, Oe M, Maeta H. Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase. Cardiovasc Res. 2002;56(1):33-42. PMID: 12237164
27. McDonald MC, Izumi M, Cuzzocrea S, Thiemermann C. A novel, potent and selective inhibitor of the activity of inducible nitric oxide synthase (GW274150) reduces the organ injury in hemorrhagic shock. J Physiol Pharmacol. 2002;53(4 Pt 1):555-69. PMID: 12512692
28. Md S, Moochhala SM, Siew Yang KL, Lu J, Anuar F, Mok P, et al. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats. J Surg Res. 2005;123(2):206-14. PMID: 15680380
29. Kan WH, Hsu JT, Schwacha MG, Choudhry MA, Raju R, Bland KI, et al. Selective inhibition of iNOS attenuates trauma-hemorrhage/resuscitation-induced hepatic injury. J Appl Physiol (1985). 2008;105(4):1076-82. doi: 10.1152/japplphysiol.90495.2008 PMID: 18635878
30. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 1993;103(2):565-75. PMID: 8432155
31. Bahrami S, Yao YM, Leichtfried G, Redl H, Marzi I, Schlag G. Significance of TNF in hemorrhage-related hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol. 1997;272(5 Pt2):H2219-26. PMID: 9176289
32. Chang R, Wang Y, Chang J, Wen L, Jiang Z, Yang T, et al. LPS preconditioning ameliorates intestinal injury in a rat model of hemorrhagic shock. Inflamm Res. 2014;63(8):675-82. doi: 10.1007/s00011-014-0740-6 PMID: 24840167
33. Lausevic Z, Lausevic M, Trbojevic-Stankovic J, Krstic S, Stojimirovic B. Predicting multiple organ failure in patients with severe trauma. Can J Surg. 2008;51(2):97-102. PMID: 18377749
34. Roumen RM, Hendriks T, Van Der Ven-Jongekrijg J, Nieuwenhuijzen GA, Sauerwein RW, Van Der Meer JW, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg. 1993;218(6):769-76. PMID: 8257227
35. Leung CH, Caldarone CA, Wang F, Venkateswaran S, Ailenberg M, Vadasz B, et al. Remote Ischemic Conditioning Prevents Lung and Liver Injury After Hemorrhagic Shock/Resuscitation: Potential Role of a Humoral Plasma Factor. Ann Surg. 2014; in press.
36. Sato H, Kasai K, Tanaka T, Kita T, Tanaka N. Role of tumor necrosis factor-alpha and interleukin-1beta on lung dysfunction following hemorrhagic shock in rats. MedSci Monit. 2008;14(5): BR79-87. PMID: 18443542
37. Alves-Rosa F, Vulcano M, Beigier-Bompadre M, Fernández G, Palermo M, Isturiz MA. Interleukin-1beta induces in vivo tolerance to lipopolysaccharide in mice. Clin Exp Immunol. 2002;128(2):221-8. PMID: 12041508